-
Mashup Score: 4The Role of Nephrectomy with Immunotherapy in Metastatic Renal Cell Carcinoma - Dimitrios Makrakis - 1 month(s) ago
Dimitrios Makrakis presents a significant meta-analysis exploring the role of cytoreductive nephrectomy in patients undergoing immune checkpoint inhibition for metastatic renal cell carcinoma. This study, a substantial effort involving 2,319 patients, sought to address the gap in understanding post-CARMENA, focusing on outcomes in the era of immune checkpoint inhibitors. The analysis, utilizing…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 22Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma - 2 month(s) ago
Analyses of longitudinal peripheral biomarkers and baseline tumor tissue from JAVELIN Renal 101 provide novel evidence of differential immunomodulatory mechanisms in patients with advanced renal cell carcinoma treated with avelumab plus axitinib versus sunitinib.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet-
From the latest issue— Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced #RenalCellCarcinoma, by @DrChoueiri, Amber Donahue et al. https://t.co/wEyDlIga7T @DanaFarber @Pfizer https://t.co/Neq5bv2dE7
-
-
Mashup Score: 12Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma - 2 month(s) ago
Analyses of longitudinal peripheral biomarkers and baseline tumor tissue from JAVELIN Renal 101 provide novel evidence of differential immunomodulatory mechanisms in patients with advanced renal cell carcinoma treated with avelumab plus axitinib versus sunitinib.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet-
From the March issue— Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced #RenalCellCarcinoma, by @DrChoueiri, Amber Donahue et al. https://t.co/VjEL4XxLWu @DanaFarber @Pfizer https://t.co/Mvm2t7DK3H
-
-
Mashup Score: 4
The authors demonstrate that there were no statistically significant differences in overall survival or time to first-line treatment failure between non-Black Hispanic and non-Hispanic White patients…
Categories: General Medicine News, Onc News and JournalsTweet-
The authors of this new study did not observe statistically significant differences in OS or time to 1st-line treatment failure between Hispanic and NHW patients with advanced #RenalCellCarcinoma. https://t.co/P6PXnEKfLE @KripaGuram @DrRanaMcKay @DrChoueiri @OncoAlert https://t.co/OHyGNlOKs9
-
-
Mashup Score: 0myTRIAList Clinical Trial: STELLAR-304 - 4 month(s) ago
Video describing the STELLAR-304 clinical trial in easy-to-understand language.
Source: www.youtube.comCategories: General Medicine News, NursingTweet-
In search of advanced or metastatic non-clear cell #RenalCellCarcinoma clinical trial options? Try searching for trials via the myTRIAList trial finder to explore clinical trial options, such as the STELLAR-304 study, that might be right for you here: https://t.co/UfAgFrEuGY https://t.co/PdhqHGdLvy
-
-
Mashup Score: 3Treatment of Recurrent Metastatic Renal Cell Carcinoma After Adjuvant Immunotherapy - Benjamin Berger & Matthew Labriola - 4 month(s) ago
Pedro Barata converses with Benjamin Berger and Matthew Labriola about their research on the treatment of recurrent metastatic RCC after adjuvant immunotherapy. They delve into the history of trials for adjuvant therapy for RCC, specifically highlighting the major advancements, challenges, and the shift to immunotherapy. The experts discuss adjuvant pembrolizumab’s approval, its effectiveness in…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Treatment of recurrent metastatic #RenalCellCarcinoma after adjuvant immunotherapy. Benjamin Berger & Matthew Labriola @DukeHealth join @PBarataMD @caseccc to discuss their research on UroToday > https://t.co/dyH0mw9loz @DukeCancer https://t.co/MZZR0h8BX3
-
-
Mashup Score: 3Treatment of Recurrent Metastatic Renal Cell Carcinoma After Adjuvant Immunotherapy - Benjamin Berger & Matthew Labriola - 5 month(s) ago
Pedro Barata converses with Benjamin Berger and Matthew Labriola about their research on the treatment of recurrent metastatic RCC after adjuvant immunotherapy. They delve into the history of trials for adjuvant therapy for RCC, specifically highlighting the major advancements, challenges, and the shift to immunotherapy. The experts discuss adjuvant pembrolizumab’s approval, its effectiveness in…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Treatment of recurrent metastatic #RenalCellCarcinoma after adjuvant immunotherapy. Benjamin Berger & Matthew Labriola @DukeHealth join @PBarataMD @caseccc to discuss their research on UroToday > https://t.co/dyH0mw9loz @DukeCancer https://t.co/MZZR0h8BX3
-
-
Mashup Score: 0
AbstractBackground:. Previous epidemiologic studies found inconsistent associations between fish consumption and renal cell carcinoma (RCC). Although the consumption of n-3 polyunsaturated fatty acids (PUFA) was reported to protect against the development of some types of cancer, little is known regarding its association with RCC.Methods:. We investigated the association between fish and n-3 PUFA consumption and RCC risk using the Japan Public Health Center-based Prospective Study. We examined data from 84,063 eligible Japanese participants aged 45 to 74 years who responded to a validated food frequency questionnaire for Cohort I in 1995 and Cohort II in 1998. The participants were followed-up until 2013. HRs and 95% confidence intervals (CI) were estimated using a multivariable-adjusted Cox proportional hazard model, and the exposure level was categorized into quartiles.Results:. Among the 1,272,298 person-years of follow-up, 262 cases of newly diagnosed RCC were identified. The multi
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet-
Takahashi et al study the association between fish consumption and #RenalCellCarcinoma and find a positive association between n-3 polyunsaturated fatty acids and RCC risk in Japanese who consume higher amounts of fish than Western populations. https://t.co/nyHx9fFDqa https://t.co/zJHuawI5ly
-
-
Mashup Score: 3Treatment of Recurrent Metastatic Renal Cell Carcinoma After Adjuvant Immunotherapy - Benjamin Berger & Matthew Labriola - 6 month(s) ago
Pedro Barata converses with Benjamin Berger and Matthew Labriola about their research on the treatment of recurrent metastatic RCC after adjuvant immunotherapy. They delve into the history of trials for adjuvant therapy for RCC, specifically highlighting the major advancements, challenges, and the shift to immunotherapy. The experts discuss adjuvant pembrolizumab’s approval, its effectiveness in…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Treatment of recurrent metastatic #RenalCellCarcinoma after adjuvant immunotherapy. Benjamin Berger & Matthew Labriola @DukeHealth join @PBarataMD @caseccc to discuss their research on UroToday > https://t.co/dyH0mw9loz @DukeCancer https://t.co/MZZR0h8BX3
-
-
Mashup Score: 0
AbstractBackground:. Previous epidemiologic studies found inconsistent associations between fish consumption and renal cell carcinoma (RCC). Although the consumption of n-3 polyunsaturated fatty acids (PUFA) was reported to protect against the development of some types of cancer, little is known regarding its association with RCC.Methods:. We investigated the association between fish and n-3 PUFA consumption and RCC risk using the Japan Public Health Center-based Prospective Study. We examined data from 84,063 eligible Japanese participants aged 45 to 74 years who responded to a validated food frequency questionnaire for Cohort I in 1995 and Cohort II in 1998. The participants were followed-up until 2013. HRs and 95% confidence intervals (CI) were estimated using a multivariable-adjusted Cox proportional hazard model, and the exposure level was categorized into quartiles.Results:. Among the 1,272,298 person-years of follow-up, 262 cases of newly diagnosed RCC were identified. The multi
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Takahashi et al study the association between fish consumption and #RenalCellCarcinoma and find a positive association between n-3 polyunsaturated fatty acids and RCC risk in Japanese who consume higher amounts of fish than Western populations. https://t.co/nyHx9fFDqa https://t.co/zJHuawI5ly
-
The role of nephrectomy with immunotherapy in metastatic #RenalCellCarcinoma. @DMakrakisMD @JacobiHosp joins @Daniel_J_George @DukeCancer to discuss gaps in understanding post-CARMENA, focusing on outcomes in the era of immune checkpoint inhibitors > https://t.co/E4YMZctL2R https://t.co/wOj68eoQ6A